scholarly journals Extremely Preterm Infant Admissions Within the SafeBoosC-III Consortium During the COVID-19 Lockdown

2021 ◽  
Vol 9 ◽  
Author(s):  
Marie Isabel Rasmussen ◽  
Mathias Lühr Hansen ◽  
Gerhard Pichler ◽  
Eugene Dempsey ◽  
Adelina Pellicer ◽  
...  

Objective: To evaluate if the number of admitted extremely preterm (EP) infants (born before 28 weeks of gestational age) differed in the neonatal intensive care units (NICUs) of the SafeBoosC-III consortium during the global lockdown when compared to the corresponding time period in 2019.Design: This is a retrospective, observational study. Forty-six out of 79 NICUs (58%) from 17 countries participated. Principal investigators were asked to report the following information: (1) Total number of EP infant admissions to their NICU in the 3 months where the lockdown restrictions were most rigorous during the first phase of the COVID-19 pandemic, (2) Similar EP infant admissions in the corresponding 3 months of 2019, (3) the level of local restrictions during the lockdown period, and (4) the local impact of the COVID-19 lockdown on the everyday life of a pregnant woman.Results: The number of EP infant admissions during the first wave of the COVID-19 pandemic was 428 compared to 457 in the corresponding 3 months in 2019 (−6.6%, 95% CI −18.2 to +7.1%, p = 0.33). There were no statistically significant differences within individual geographic regions and no significant association between the level of lockdown restrictions and difference in the number of EP infant admissions. A post-hoc analysis based on data from the 46 NICUs found a decrease of 10.3%in the total number of NICU admissions (n = 7,499 in 2020 vs. n = 8,362 in 2019).Conclusion: This ad hoc study did not confirm previous reports of a major reduction in the number of extremely pretermbirths during the first phase of the COVID-19 pandemic.Clinical Trial Registration:ClinicalTrial.gov, identifier: NCT04527601 (registered August 26, 2020), https://clinicaltrials.gov/ct2/show/NCT04527601.

Author(s):  
Marie Isabel Rasmussen ◽  
Mathias Lühr Hansen ◽  
Gerhard Pichler ◽  
Eugene Dempsey ◽  
Adelina Pellicer ◽  
...  

AbstractObjectiveTo evaluate if the number of admitted extremely preterm (EP) infants (born before 28 weeks of gestational age) has changed in the neonatal intensive care units (NICUs) of the SafeBoosC-III consortium during the global lockdown when compared to the corresponding time period in 2019.DesignThis is a retrospective, observational study. Forty-six out of 79 NICUs (58%) from 17 countries participated. Principal investigators were asked to report the following information: 1) Total number of EP infant admissions to their NICU in the three months where the lockdown restrictions were most rigorous during the first phase of the COVID-19 pandemic, 2) Similar EP infant admissions in the corresponding three months of 2019, 3) the level of local restrictions during the lockdown period and 4) the local impact of the COVID-19 lockdown on the everyday life of a pregnant woman.ResultsThere was no significant difference between the number of EP infant admissions during the three most rigorous lockdown months of the COVID-19 pandemic compared to the corresponding three months in 2019 (n=428 versus n=457 respectively, p=0.33). There were no significant changes within individual geographic regions and no significant association between the level of lockdown restrictions and change in the number of EP infant admissions (p=0.334).ConclusionThis larger ad hoc study did not confirm previous studies’ report of a major reduction in the number of extremely preterm births during the first phase of the COVID-19 pandemic.


2021 ◽  
pp. 097321792110076
Author(s):  
Gwendolyn Schultz ◽  
Majida Gaffar

Purpose: To report the use of a centralized electronic medical record (EMR) to provide timely retinopathy of prematurity (ROP) screening in a previously fragmented monitoring system in a standalone children’s hospital in Connecticut. Methods: A chart review of 306 visits for ROP screening in 3 neonatal intensive care units (NICUs) over a time period of 24 months. Results: All infants born at <30 weeks gestational age or birth weight <1,500g (N = 107) at these NICUs were screened for ROP according to the American Academy of Pediatrics guidelines. Data was collected before the implementation of our centralized EMR list, during a transitional period, and once the list was established. Our analysis of the data found an improvement in delay of care from 16.85% to 10.83% of visits, and a decrease in number of visits done during off hours from 20.4% to 5% of visits. Conclusion: Our tool was a free and cost-efficient centralization of a once difficult-to-manage process for ROP screenings in Connecticut. The decrease in delay of care and improvement in physician scheduling will lead to better outcomes for our patients and better sustainability of practice for our providers.


2017 ◽  
Vol 35 (03) ◽  
pp. 233-241
Author(s):  
Mohamed Elboraee ◽  
Jennifer Toye ◽  
Xiang Ye ◽  
Prakesh Shah ◽  
Khalid Aziz ◽  
...  

Objective The objective of this study was to examine the association between umbilical catheters and a composite outcome of mortality or major neonatal morbidity in extremely preterm infants. Study Design Data were abstracted from the Canadian Neonatal Network database for infants born at <29 weeks' gestational age and admitted to 29 neonatal intensive care units between January 2010 and December 2012. Four groups were identified: those with no umbilical catheters, umbilical venous catheters (UVCs), umbilical artery catheters (UACs), and those with both UVCs and UACs. The outcomes were compared among the groups using univariate and multivariable analyses. Results Of 4,623 eligible infants, 820 (17.7%) had no catheters, 1,032 (22.3%) a UVC only, 120 (2.6%) a UAC only, and 2,651 (57.3%) had both catheters. After adjustment for acuity and other potential confounders, umbilical catheters were associated with higher odds of mortality or any major morbidity (UVC vs. no catheter: adjusted odds ratio [aOR]: 1.47; 95% CI: 1.18–1.85; UAC vs. no catheter: aOR: 1.67; 95% CI: 1.05–2.63; and both UVC + UAC vs. no catheter: aOR: 2.17; 95% CI: 1.79–2.70). Conclusion Most of the infants born at <29 weeks' gestation had UVC and/or UAC placement. The presence of either catheter was associated with mortality or major morbidity, and the association was stronger when both catheters were present.


2021 ◽  
Vol 9 ◽  
Author(s):  
Jenny Bua ◽  
Ilaria Mariani ◽  
Martina Girardelli ◽  
Murphy Tomadin ◽  
Antonella Tripani ◽  
...  

Background: Recent studies reported, during the COVID-19 pandemic, increased mental distress among the general population and among women around the childbirth period. COVID-19 pandemic may undermine the vulnerable well-being of parents in Neonatal Intensive Care Units (NICUs).Objective: Our study aimed to explore whether parental stress, depression, and participation in care in an Italian NICU changed significantly over three periods: pre-pandemic (T0), low (T1), and high COVID-19 incidence (T2).Methods: Enrolled parents were assessed with the Parental Stressor Scale in the NICU (PSS:NICU), Edinburgh Postnatal Depression Scale (EPDS), and Index of Parental Participation (IPP). Stress was the study primary outcome. A sample of 108 parents, 34 for each time period, was estimated to be adequate to detect a difference in PSS:NICU stress occurrence level score (SOL) of 1.25 points between time periods. To estimate score differences among the three study periods a non-parametric analysis was performed. Correlation among scores was assessed with Spearman rank coefficient.Results: Overall, 152 parents were included in the study (62 in T0, 56 in T1, and 34 in T2). No significant differences in the median PSS:NICU, EPDS, and IPP scores were observed over the three periods, except for a slight increase in the PSS:NICU parental role sub-score in T2 (T0 3.3 [2.3–4.1] vs. T2 3.9 [3.1–4.3]; p = 0.038). In particular, the question regarding the separation from the infant resulted the most stressful aspect during T2 (T0 4.0 [4.0–5.0] vs. T2 5.0 [4.0–5.0], p = 0.008). The correlation between participation and stress scores (r = 0.19–022), and between participation and depression scores (r = 0.27) were weak, while among depression and stress, a moderate positive correlation was found (r = 0.45–0.48).Conclusions: This study suggests that parental stress and depression may be contained during the COVID-19 pandemic, while participation may be ensured.


2008 ◽  
Vol 57 (2) ◽  
Author(s):  
Adriano Bompiani

Il Protocollo di Gröningen e la Carta di Firenze hanno sollevato nell’opinione pubblica questioni sull’assistenza ostetrico-pediatrica da tempo dibattute in sede scientifica e professionale, riguardanti i criteri assistenziali cui sono sottoposti – attualmente – i nati estremamente prematuri per settimana di gestazione (22-25) e/o di peso estremamente ridotto (inferiore a 1000 gr). L’A. affronta l’argomento partendo da una rassegna – notevolmente ampia – della letteratura in merito, ripartita per anni di attività della neonatologia intensivista, sia alla luce dello “stile di risposta” dei vari Centri attivi, sia dei progressi terapeutici intervenuti negli anni (uso prenatale di glicocorticoidi; uso neonatale di surfattante polmonare; assistenza ventilatoria strumentale, etc.). Esamina successivamente i contenuti del Protocollo di Gröningen e della Carta di Firenze, rilevandone notevoli differenze di applicazione ma anche tratti comuni nella posizione pregiudiziale di “non rianimare” il neonato al di sotto di determinati limiti temporali di sviluppo (peraltro attenuata dalla previsione di condizioni eccezionali di vitalità neonatale nella Carta di Firenze). Descritti, alla luce delle indagini epidemiologiche, gli esiti neurologici e polmonari dei sopravvissuti e gli atteggiamenti – in vari Paesi – dei neonatologi, espone gli elementi giuridici riguardanti la posizione del neonato alla luce delle fondamentali Dichiarazioni del Diritto Internazionale riguardanti la persona umana e della Carta Costituzionale Italiana, con relative norme applicative. Anche sulla base di elaborazioni etiche – estesamente esaminate – , e rifiutando ogni impostazione eutanasica, l’A. propende per una linea assistenziale che favorisca la rianimazione (primaria e secondaria) del nato estremamente prematuro, nei limiti tuttavia in cui lo stato di vitalità alla nascita e l’evoluzione del caso nelle Unità di terapia intensiva favoriscano il rispetto del “principio di proporzionalità delle cure”. Si conviene sulla necessità della costante comunicazione con i genitori nella discussione delle linee terapeutiche più opportune, ma si riconosce che il neonatologo intensivista è il responsabile – a termine di legge – delle decisioni terapeutiche. ---------- The Gröningen Protocol and the Florence Chart have raised in the public opinion issues on the obstetrician-paediatric care debated in scientific and professional centres for a long time, regarding the health care criteria to which extremely preterm infants are – currently – subordinated for week of gestation (22-25) and/or for extremely reduced weight (lower than 1000 gr). The author debates starting from a review – remarkably wide – of the literature, shared among years of intensive neonatology activity both in the light of the “answer style” of the different centres and of the therapeutic progresses in the last years (prenatal use of glycocorticoides; neonatal use of pulmonary surfactant; mechanics of artificial breathing, etc.). He subsequently examines the contents of the Gröningen Protocol and of the Florence Chart, finding some remarkable differences of application but also common features in prejudicial position of the “do not resuscitate” infants under determine temporal limits of development (moreover attenuated from the prediction of exceptional conditions of neonatal vitality in Florence Chart). Once described, in the light of epidemiologic researches, the survivors neurological and pulmonary outcomes and the neonatologists attitudes – in several Countries – he exposes the legal elements regarding the position of the infants in the light of the Declarations of International Law on human person and Italian Constitution, with their applicative norms. Also according to ethical statements – extensively examined –, and refusing all euthanasian formulation, the author is inclined for a line that can favour the resuscitation (primary and secondary) of the extremely premature infant, however, insofar as the limits in which the state of viability at the birth and the evolution of the case in the neonatal intensive care units favour the respect of the principle of proportionality of care. He agrees on the necessity of the constant dialogue with the parents discussing the more opportune therapeutic lines, but acknowledging that the intensive neonatologist is the responsible – according to law – of the therapeutic decisions.


2015 ◽  
Vol 101 (1) ◽  
pp. e1.3-e1
Author(s):  
Inge Mesek ◽  
Georgi Nellis ◽  
Jana Lass ◽  
Irja Lutsar

ObjectivesThis is the first Europe-wide study aiming to describe the medication use in Neonatal Intensive Care Units and to analyse the factors that might influence the prescription pattern.MethodsA pan-European one day point-prevalence study was conducted in 2012 where all of the prescriptions for hospitalised neonates were recorded. A trade name, manufacturer, active pharmaceutical ingredients (API), strength, galenic form and route of administration were registered.ResultsAltogether 2173 prescriptions were administered to 726 neonates from 21 countries, of whom 66% (477/726) were preterm, 12% (84/726) extremely preterm. There was inverse correlation between gestational age (GA) and median number of prescriptions per neonate (group median 2/IQR 1–4, extremely preterm 4/3–6, very preterm 3/2–5, late preterm 2/1–3, full-term 2/1–3). Median number of prescriptions per neonate was highest in the eastern region, among extremely preterm neonates (median=6.5/IQR 6–8.5). Highest prescription rate was for alimentary medicines (93/per 100 admissions), systemic antiinfectives (79/100) and medicines for blood (71/100). Antiinfectives were most frequently prescribed in the southern region (103/100). Multivitamins were most frequently used medications in most regions (western 74, southern 31, northern 31/100), except in eastern region (5/100). Most commonly prescribed API-s were multivitamins (32/100), caffeine (19/100), gentamicin (18/100), amino acids (18/100) and colecalciferol (15/100). Most frequently prescribed medications among extremely preterm neonates were caffeine (60/100), among very preterms multivitamins and caffeine (45 and 43/100), among late preterms multivitamins (44/100) and among full-terms phytomenadione (26/100) and gentamicin (24/100).ConclusionsOur study revealed the most commonly used medications in neonates. Higher prescription rate among preterm neonates calls for further analysis of the suitability and safety of medications for infants with lower GA.


BMJ Open ◽  
2019 ◽  
Vol 9 (3) ◽  
pp. e024560 ◽  
Author(s):  
Mark Adams ◽  
Thomas M Berger ◽  
Cristina Borradori-Tolsa ◽  
Myriam Bickle-Graz ◽  
Sebastian Grunt ◽  
...  

ObjectivesTo investigate if centre-specific levels of perinatal interventional activity were associated with neonatal and neurodevelopmental outcome at 2 years of age in two separately analysed cohorts of infants: cohort A born at 22–25 and cohort B born at 26–27 gestational weeks, respectively.DesignGeographically defined, retrospective cohort study.SettingAll nine level III perinatal centres (neonatal intensive care units and affiliated obstetrical services) in Switzerland.PatientsAll live-born infants in Switzerland in 2006–2013 below 28 gestational weeks, excluding infants with major congenital malformation.Outcome measuresOutcomes at 2 years corrected for prematurity were mortality, survival with any major neonatal morbidity and with severe-to-moderate neurodevelopmental impairment (NDI).ResultsCohort A associated birth in a centre with high perinatal activity with low mortality adjusted OR (aOR 0.22; 95% CI 0.16 to 0.32), while no association was observed with survival with major morbidity (aOR 0.74; 95% CI 0.46 to 1.19) and with NDI (aOR 0.97; 95% CI 0.46 to 2.02). Median age at death (8 vs 4 days) and length of stay (100 vs 73 days) were higher in high than in low activity centres. The results for cohort B mirrored those for cohort A.ConclusionsCentres with high perinatal activity in Switzerland have a significantly lower risk for mortality while having comparable outcomes among survivors. This confirms the results of other studies but in a geographically defined area applying a more restrictive approach to initiation of perinatal intensive care than previous studies. The study adds that infants up to 28 weeks benefited from a higher perinatal activity and why further research is required to better estimate the added burden on children who ultimately do not survive.


2019 ◽  
Vol 34 (6) ◽  
pp. 313-320 ◽  
Author(s):  
Sarah Grace Buttle ◽  
Brigitte Lemyre ◽  
Erick Sell ◽  
Stephanie Redpath ◽  
Srinivas Bulusu ◽  
...  

Background/Objective: Seizure monitoring via amplitude-integrated EEG is standard of care in many neonatal intensive care units; however, conventional EEG is the gold standard for seizure detection. We compared the diagnostic yield of amplitude-integrated EEG interpreted at the bedside, amplitude-integrated EEG interpreted by an expert, and conventional EEG. Methods: Neonates requiring seizure monitoring received amplitude-integrated EEG and conventional EEG in parallel. Clinical events and amplitude-integrated EEG were interpreted at bedside. Subsequently, amplitude-integrated EEG and conventional EEG were independently analyzed by experienced neonatology and neurology readers. Sensitivity and specificity of bedside amplitude-integrated EEG as compared to expert amplitude-integrated EEG interpretation and conventional EEG were evaluated. Results: Thirteen neonates were monitored for an average duration of 33 hours (range 15-94, SD 25). Fourteen seizure-like events were detected by clinical observation, and 12 others by bedside amplitude-integrated EEG analysis. One of the clinical, and none of the bedside amplitude-integrated EEG events were confirmed as seizures on conventional EEG. Post hoc expert amplitude-integrated EEG interpretation revealed eight suspected seizures, all different from the ones detected by the bedside amplitude-integrated EEG team, of which one was confirmed via conventional EEG. Eight seizures were recorded on conventional EEG. Expert amplitude-integrated EEG interpretation had a sensitivity of 13% with 46% specificity for individual seizure detection, and a sensitivity of 50% with 46% specificity for detecting patients with seizures. Conclusion: Real-world bedside amplitude-integrated EEG monitoring failed to detect all seizures evidenced via conventional EEG, while misclassifying other events as seizures. Even post hoc expert amplitude-integrated EEG interpretation provided limited sensitivity and specificity. Considering the poor sensitivity and specificity of bedside amplitude-integrated EEG interpretation, combined monitoring may provide limited clinical benefit.


2021 ◽  
Vol 9 ◽  
Author(s):  
Ningxin Luo ◽  
Siyuan Jiang ◽  
Patrick J. McNamara ◽  
Xiaoying Li ◽  
Yan Guo ◽  
...  

Objective: To describe cardiovascular pharmacological support in infants born at &lt;34 weeks' gestation within the first postnatal week in Chinese neonatal intensive care units (NICUs).Design: A secondary analysis of data from a multicenter randomized controlled study (REIN-EPIQ). A questionnaire regarding cardiovascular support practices was also completed by all participating NICUs.Setting: Twenty-five tertiary hospitals from 19 provinces in China.Patients: All infants born at &lt;34 weeks' gestation and admitted to participating NICUs within the first postnatal week from May 2015 to April 2018 were included. Infants who were discharged against medical advice were excluded.Measures and Main Results: Among the 26,212 preterm infants &lt;34 weeks, 16.1% received cardiovascular pharmacological support. The use rates increased with decreasing gestational age and birth weight, with 32.5% among infants &lt;28 weeks and 35.9% among infants &lt;1,000 g. Cardiovascular pharmacological support was independently associated with higher risks of death (aOR 2.8; 95% CI 2.4–3.3), severe intraventricular hemorrhage (IVH) (aOR 2.1; 95% CI 1.8–2.5) and bronchopulmonary dysplasia (BPD) (aOR 2.2; 95% CI 2.0–2.5). Overall 63.1% courses of cardiovascular pharmacological support were &gt;3 days. Prolonged cardiovascular pharmacological support (&gt;3 days) was independently associated with lower rates of survival without morbidity in very-low-birth-weight infants, compared with infants with shorter durations. Dopamine was the most commonly used cardiovascular agent. The cardiovascular pharmacological support rates varied from 1.9 to 65.8% among the participating NICUs.Conclusions: The rate of cardiovascular pharmacological support within the first postnatal week was high with prolonged durations in Chinese NICUs. Marked variation in cardiovascular support existed among participating NICUs. Cardiovascular pharmacological support during the early postnatal period, especially prolonged, may be associated with adverse neonatal outcomes.Clinical Trial Registration: The original trial was registered as “Reduction of Infection in Neonatal Intensive Care Units using the Evidence-based Practice for Improving Quality” (ID: NCT02600195) on clinicaltrials.gov. https://clinicaltrials.gov/ct2/show/NCT02600195?term=NCT02600195&amp;draw=2&amp;rank=1.


Sign in / Sign up

Export Citation Format

Share Document